Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.
about
Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intakeRelation of serum serotonin levels to bone density and structural parameters in womenLrp5 controls bone formation by inhibiting serotonin synthesis in the duodenumAn overlooked connection: serotonergic mediation of estrogen-related physiology and pathology.The treatment of depressive disorders in epilepsy: what all neurologists should knowThe haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetineResonance in the mouse tibia as a predictor of frequencies and locations of loading-induced bone formationThe serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation.The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels.An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia.A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic RelevanceEffect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase CUpdate in serotonin and bone.Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.Minireview: A skeleton in serotonin's closet?Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studiesThe associations of serum serotonin with bone traits are age- and gender-specific.Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?Psychotropic medication use in anorexia nervosa between 1997 and 2009.Update on medications with adverse skeletal effectsEvaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.Decreased osteoclastogenesis in serotonin-deficient mice.Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats.SSRIs: bad to the bone?The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis.Brains, bones, and aging: psychotropic medications and bone health among older adults.Use of antidepressant medications and risk of fracture in older womenLife without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks.Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression.Serotonin and the regulation of mammalian energy balance.Regulation of bone remodeling by the central and peripheral nervous systemAntidepressants and fracture risk in older adults: a comparative safety analysis.Depression and osteoporosis: epidemiology and potential mediating pathways.Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice.
P2860
Q21134750-3D686FBC-12A9-480D-8756-CBA06380AF05Q24620295-A581AB7E-BDEB-4347-BE00-D3FB184CD603Q24653502-52F65363-4551-49F0-8195-B2777FF84752Q25257354-8C94677B-C4CB-4DE4-8E94-DE96A5E03BB9Q26851858-DDD50C32-A4E7-4D29-8C60-DEFABD973EFDQ27319893-7DB6FB52-D865-4CF4-8F05-24B2C3DB8D83Q28384165-E79050CB-2BB3-40A2-B85B-AFBA8C244592Q28387175-F80167BF-3B46-404D-B957-B6D434206E78Q33617543-9B8AFC5A-6FAB-49E0-9E7B-657883936CEEQ33635906-C30FB78F-56AC-4598-BB52-1281D80F6E91Q33742105-08B96B2E-FA68-4B9C-9CC6-20AC594E68CAQ33746712-F15241B3-FFBA-46D8-ABCB-90C22DBA1EF2Q33755068-674B4FF6-4A67-4E5F-B590-9A60968578AAQ33789841-C8CCA365-E1EE-4D42-B0CD-B4471897D3FEQ33926234-3997F171-3A31-4847-9C65-5E93CB39C974Q33955124-1EE12F8B-5E71-4245-A44A-83DDCE2C5E4BQ34074295-23BCF7B1-AF41-4890-98DE-BA2A351B5AD0Q34113148-06909771-AB7E-4854-A804-F248990DEBC3Q34127450-932A670C-0D7D-4052-AB84-866F64029165Q34132327-D9B6162F-DEDD-4CE3-B4B6-61ADC11CC80CQ34140313-BC819C42-91C6-488E-8438-8756B5A720F1Q34287323-E4956C2E-DB78-4DD4-A705-2C89D629A061Q34536565-5D06B0C0-7368-4023-AC2B-CFB17C26A548Q34639626-3500DCA2-72CD-46AA-AE7E-8ADBD8D0BAA3Q34748485-4FD9BD73-5B19-4799-83D5-4C874663F5E5Q34863279-ADFF4CEA-6A29-40B1-B19E-8E90A42C0929Q34956921-EC015C6A-5C9A-4A3C-85F9-D5D719B79560Q35787005-04BB59A8-2F5C-4654-B141-D7BCA70EE3E8Q35933172-26931FBD-1FC0-4556-BBDB-DC3FF2A84793Q36235126-4A95AB73-9978-4895-8855-DBCAC5A9B071Q36415999-97568A40-2A2C-4E54-AF87-8C5C8E4819D6Q36427958-0E213FC5-028A-4E62-B584-5CCB5AD0DABCQ36526151-58E0A98B-4348-4B85-B912-995866F73AD9Q36540919-3D485E56-D63D-4161-85F5-BAF2B7395A45Q36637677-834A78E9-0F39-467E-A065-62FD68904E20Q36718579-8C36C67A-3905-4630-9173-259B9B2B5E2EQ36724983-B7164DA8-E6B7-43D6-8B7D-05FAB276F0BEQ36817545-AE66EB76-77E5-4166-95CA-38A9E992DD71Q36925842-CCA3DAAD-7FBF-4F81-AAAF-6E57DB81DA78Q37014700-2E80B79E-95C8-4934-B82A-921B4932939D
P2860
Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Inhibition of the serotonin (5 ...... es bone accrual during growth.
@en
Inhibition of the serotonin
@nl
type
label
Inhibition of the serotonin (5 ...... es bone accrual during growth.
@en
Inhibition of the serotonin
@nl
prefLabel
Inhibition of the serotonin (5 ...... es bone accrual during growth.
@en
Inhibition of the serotonin
@nl
P2093
P356
P1433
P1476
Inhibition of the serotonin (5 ...... es bone accrual during growth.
@en
P2093
Alexander G Robling
Charles H Turner
Megan S Sanders
Michael M Bliziotes
P304
P356
10.1210/EN.2004-1259
P407
P577
2004-11-11T00:00:00Z